Calamari SE, Bojanich MA, Barembaum
SR, Berdicevski N, Azcurra AI. Antifungal and post-antifungal effects of chlorhexidine,
fluconazole, chitosan and
its combinations on Candida albicans. Med Oral
Patol Oral Cir Bucal. 2011 Jan
1;16 (1):e23-8.
doi:10.4317/medoral.16.e23
http://dx.doi.org/doi:10.4317/medoral.16.e23
1. Lopez-De-Blanc
SA, Salati-De-Mugnolo N, Femopase FL, Benitez MB, Morelatto RA, Astrada-De-Verde L,
et al. Antifungal topical therapy in oral chronic candidosis. A comparative study.
Med Oral. 2002;7:260-70.
PMid:12134127
2. Kliemann DA, Pasqualotto
AC, Falavigna M, Giaretta
T, Severo LC. Candida esophagitis:
species distribution and risk factors for infection. Rev Inst Med Trop Sao Paulo. 2008;50:261-3.
doi:10.1590/S0036-46652008000500002
3. Azcurra
AI, Barembaum SR, Bojanich
MA, Calamari SE, Aguilar J, Battellino LJ, et al.
Effect of the high molecular weight chitosan and
sodium alginate on Candida albicans hydrophobicity and adhesion to cells. Med Oral Patol Oral Cir Bucal. 2006;11:E120-5.
4. Baena-Monroy T, Moreno-Maldonado V,
Franco-Martínez F, Aldape-Barrios B, Quindós G, Sánchez-Vargas LO. Candida albicans,
Staphylococcus aureus and Streptococcus mutans colonization in patients wearing dental prosthesis. Med Oral Patol Oral Cir Bucal. 2005;10 Suppl 1:E27-39.
5. Singleton DR, Masuoka J, Hazen KC. Surface hydrophobicity changes of two Candida albicans
serotype B mnn4delta mutants. Eukaryot Cell. 2005;4:639-48.
doi:10.1128/EC.4.4.639-648.2005
PMid:15821124 PMCid:1087808
6. Vidotto
V, Yumi Koga-Ito C, Milano R, Fianchino
B, Pontón J. Correlation between germ tube
production, phospholipase activity and serotype
distribution in Candida albicans. Rev Iberoam Micol. 1999;16:208-10.
PMid:18473549
7. Kadir T, Gümrü B, Uygun-Can B. Phospholipase
activity of Candida albicans isolates from patients
with denture stomatitis: the influence of chlorhexidine gluconate on phospholipase production. Arch Oral Biol. 2007;52:691-6.
doi:10.1016/j.archoralbio.2006.12.008
PMid:17241611
8. Egusa
H, Ellepola AN, Nikawa H,
Hamada T, Samaranayake LP. Sub-therapeutic
exposure to polyene antimycotics
elicits a post-antifungal effect (PAFE) and depresses the cell surface hydrophobicity of oral Candida albicans
isolates. J Oral Pathol Med. 2000;29:206-13.
doi:10.1034/j.1600-0714.2000.290503.x
PMid:10801037
9. Denning DW, Hope WW. Therapy for fungal diseases:
opportunities and priorities. Trends Microbiol.
2010;18:195-204.
doi:10.1016/j.tim.2010.02.004
PMid:20207544
10. Barasch A, Safford MM, Dapkute-Marcus I, Fine
DH. Efficacy of chlorhexidine gluconate rinse for treatment and prevention of oral candidiasis in HIV-infected children: a pilot study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004;97:204-7.
doi:10.1016/j.tripleo.2003.09.005
11. Navarathna DH, Hornby JM, Hoerrmann N, Parkhurst AM,
Duhamel GE, Nickerson KW. Enhanced pathogenicity of
Candida albicans pre-treated with subinhibitory
concentrations of fluconazole in a mouse model of
disseminated candidiasis. J Antimicrob Chemother. 2005;56:1156-9.
doi:10.1093/jac/dki383
PMid:16239285
12. Lyon JP, De Resende MA.
Correlation between adhesion, enzyme production, and susceptibility to fluconazole in Candida albicans
obtained from denture wearers. Oral Surg
Oral Med Oral Pathol Oral Radiol
Endod. 2006;102:632-8.
doi:10.1016/j.tripleo.2005.12.015
PMid:17052640
13. Koide SS. Chitin-chitosan: properties, benefits
and risks. Nutrition Research. 1998;18:1091-101.
doi:10.1016/S0271-5317(98)00091-8
14. Barembaum S, Virga C, Bojanich A, Cornejo L, Calamari
S, Pontón J, et al. Effect of Chitosan
and Sodium Alginate on the adherence of autochthonous C. Albicans
to oral epithelial cells (in vitro). Med Oral. 2003;8:188-96.
PMid:12730653
15. Rossi S, Sandri G, Ferrari F, Bonferoni
MC, Caramella C. Buccal
delivery of acyclovir from films based on chitosan
and polyacrylic acid. Pharm
Dev Technol. 2003;8:199-208.
doi:10.1081/PDT-120018490
PMid:12760570
16. Calamari S, Bojanich A, Barembaum
S, Azcurra A, Virga C, Dorronsoro S. [High molecular weight chitosan
and sodium alginate effect on secretory acid proteinase of Candida albicans].
Rev Iberoam Micol. 2004;21:206-8.
PMid:15709803
17. Seyfarth F, Schliemann S, Elsner
P, Hipler UC. Antifungal effect of
high- and low-molecular-weight chitosan
hydrochloride, carboxymethyl chitosan,
chitosan oligosaccharide and N-acetyl-D-glucosamine
against Candida albicans, Candida krusei
and Candida glabrata. Int
J Pharm. 2008;353:139-48.
PMid:18164151
18. García-Martos P, García-Agudo
R, Hernández-Molina JM, Marín
P, Tallero E, Mira J. [Identification of yeasts of
clinical interest on CHROMagar Candida culture
medium.]. Rev
Iberoam Micol. 1998;15:131-5.
19. Carrillo-Muñoz AJ, Quindós G, Ruesga
M, Alonso R, Del Valle O, Hernández-Molina JM, et al. Antifungal activity of posaconazole
compared with fluconazole and amphotericin
B against yeasts from oropharyngeal candidiasis and other infections. J Antimicrob Chemother. 2005;55:317-9.
doi:10.1093/jac/dki022
PMid:15705637
20. Anil S, Ellepola AN, Samaranayake LP. The impact of chlorhexidine gluconate on the
relative cell surface hydrophobicity of oral Candida albicans. Oral Dis. 2001;7:119-22.
doi:10.1034/j.1601-0825.2001.70210.x
PMid:11355437
21. Yoshida T, Jono K, Okonogi
K. Modified agar dilution susceptibility testing method for determining in
vitro activities of antifungal agents, including azole
compounds. Antimicrob Agents Chemother. 1997;41:1349-51.
PMid:9174197 PMCid:163913
22. Ellepola AN, Samaranayake LP. The effect of brief exposure to sub-therapeutic concentrations of chlorhexidine gluconate on the
germ tube formation of oral Candida albicans and its
relationship to post-antifungal effect. Oral Dis. 2000;6:166-71.
doi:10.1111/j.1601-0825.2000.tb00328.x
23. Goldberg S,
Doyle RJ, Rosenberg M. Mechanism of enhancement of microbial cell hydrophobicity by cationic polymers. J Bacteriol. 1990;172:5650-4.
PMid:2211502 PMCid:526878
24. Hube B, Stehr F, Bossenz M, Mazur A, Kretschmar M,
Schäfer W. Secreted lipases of Candida albicans: cloning, characterisation
and expression analysis of a new gene family with at least ten members. Arch Microbiol. 2000;174:362-74.
doi:10.1007/s002030000218
PMid:11131027
25. Masuoka J, Hazen KC. Cell wall mannan and cell surface hydrophobicity
in Candida albicans serotype A and B strains. Infect
Immun. 2004;72:6230-6.
doi:10.1128/IAI.72.11.6230-6236.2004
PMid:15501748 PMCid:523023
26. Senel S, Ikinci G, Kaş S, Yousefi-Rad A, Sargon
MF, Hincal AA. Chitosan films and hydrogels of chlorhexidine gluconate for oral
mucosal delivery. Int J Pharm. 2000;193:197-203.
doi:10.1016/S0378-5173(99)00334-8
27. Giunchedi P, Juliano C,
Gavini E, Cossu M, Sorrenti M. Formulation and in vivo evaluation of chlorhexidine buccal tablets
prepared using drug-loaded chitosan microspheres. Eur J Pharm Biopharm.
2002;53:233-9.
doi:10.1016/S0939-6411(01)00237-5
28. Ellepola AN, Samaranayake LP. Adjunctive
use of chlorhexidine in oral candidoses:
a review. Oral Dis. 2001;7:11-7.
doi:10.1034/j.1601-0825.2001.70103.x
PMid:11354914
29. Pinto E, Ribeiro IC, Ferreira NJ, Fortes CE,
Fonseca PA, Figueiral MH. Correlation between enzyme production, germ tube
formation and susceptibility to fluconazole in
Candida species isolated from patients with denture-related stomatitis
and control individuals. J Oral Pathol
Med. 2008;37:587-92.
doi:10.1111/j.1600-0714.2008.00687.x
PMid:18764856